Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 2
2009 2
2010 4
2011 3
2013 1
2014 1
2015 3
2017 2
2019 5
2020 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Micro- and nanocarriers for pain alleviation.
da Silva A, Lepetre-Mouelhi S, Couvreur P. da Silva A, et al. Among authors: lepetre mouelhi s. Adv Drug Deliv Rev. 2022 Aug;187:114359. doi: 10.1016/j.addr.2022.114359. Epub 2022 May 30. Adv Drug Deliv Rev. 2022. PMID: 35654211 Review.
Adenosine and lipids: A forced marriage or a love match?
Rouquette M, Lepetre-Mouelhi S, Couvreur P. Rouquette M, et al. Among authors: lepetre mouelhi s. Adv Drug Deliv Rev. 2019 Nov-Dec;151-152:233-244. doi: 10.1016/j.addr.2019.02.005. Epub 2019 Feb 21. Adv Drug Deliv Rev. 2019. PMID: 30797954 Review.
Towards a clinical application of freeze-dried squalene-based nanomedicines.
Rouquette M, Ser-Le Roux K, Polrot M, Bourgaux C, Michel JP, Testard F, Gobeaux F, Lepetre-Mouelhi S. Rouquette M, et al. Among authors: lepetre mouelhi s. J Drug Target. 2019 Jun-Jul;27(5-6):699-708. doi: 10.1080/1061186X.2019.1566340. Epub 2019 Feb 21. J Drug Target. 2019. PMID: 30786788
Squalene-Adenosine Nanoparticles: Ligands of Adenosine Receptors or Adenosine Prodrug?
Rouquette M, Lepetre-Mouelhi S, Dufrançais O, Yang X, Mougin J, Pieters G, Garcia-Argote S, IJzerman AP, Couvreur P. Rouquette M, et al. Among authors: lepetre mouelhi s. J Pharmacol Exp Ther. 2019 Apr;369(1):144-151. doi: 10.1124/jpet.118.254961. Epub 2019 Jan 22. J Pharmacol Exp Ther. 2019. PMID: 30670479
Squalenoyl nanomedicines as potential therapeutics.
Couvreur P, Stella B, Reddy LH, Hillaireau H, Dubernet C, Desmaële D, Lepêtre-Mouelhi S, Rocco F, Dereuddre-Bosquet N, Clayette P, Rosilio V, Marsaud V, Renoir JM, Cattel L. Couvreur P, et al. Among authors: lepetre mouelhi s. Nano Lett. 2006 Nov;6(11):2544-8. doi: 10.1021/nl061942q. Nano Lett. 2006. PMID: 17090088
Translation of nanomedicines from lab to industrial scale synthesis: The case of squalene-adenosine nanoparticles.
Dormont F, Rouquette M, Mahatsekake C, Gobeaux F, Peramo A, Brusini R, Calet S, Testard F, Lepetre-Mouelhi S, Desmaële D, Varna M, Couvreur P. Dormont F, et al. Among authors: lepetre mouelhi s. J Control Release. 2019 Aug 10;307:302-314. doi: 10.1016/j.jconrel.2019.06.040. Epub 2019 Jun 29. J Control Release. 2019. PMID: 31260754 Free article.
27 results